Listed
Stock Code: 078160
| Company Name | 메디포스트(주) |
| English Name | MEDIPOSTCO.,LTD. |
| Business Reg. No. | 2118661218 |
| CEO | 오원일 |
| Address | 경기도 성남시 분당구 대왕판교로 644번길21 - |
| Industry | 기초 의약 물질 제조업 |
| Industry Code | 211 |
| Established | 2000-06-26 |
| Phone | 02-3465-6677 |
| Website | www.medi-post.co.kr |
| Regular Employees | 329persons |
| Corp. Reg. No. | 1101112007709 |
Venture Certified
| 신기술기업(고도기술수반산업) | 2001-03-31 ~ 2003-03-30 | 20011622712972 | 2001-03-31 |
| 신기술기업(고도기술수반산업) | 2003-03-31 ~ 2005-03-30 | 031622032200347 | 2001-03-31 |
| 신기술기업(고도기술수반산업) | 2005-03-31 ~ 2007-03-30 | 051122032301148 | 2001-03-31 |
| 연구개발유형 | 2007-03-31 ~ 2009-03-30 | 20070400070 | 2001-03-31 |
| 연구개발유형 | 2009-03-31 ~ 2011-03-30 | 20090400160 | 2001-03-31 |
| 연구개발유형 | 2011-03-31 ~ 2013-03-30 | 20110400125 | 2001-03-31 |
| 연구개발유형 | 2015-06-04 ~ 2017-06-03 | 20150400654 | 2001-03-31 |
| 연구개발유형 | 2017-06-04 ~ 2019-06-03 | 20170401038 | 2001-03-31 |
| 연구개발유형 | 2019-06-04 ~ 2021-06-03 | 20190401216 | 2001-03-31 |
| 혁신성장유형 | 2021-06-04 ~ 2024-06-03 | 20210804030051 | 2001-03-31 |
| 벤처투자유형 | 2024-10-10 ~ 2027-10-09 | 20241010010039 | 2001-03-31 |
Revenue CAGR +9.9%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 741B | 697B | 614B |
| Operating Profit | 38B | 36B | -108B |
| Net Profit | -618B | 67B | 104B |
| Total Assets | 4,098B | 4,443B | 3,944B |
| Total Liabilities | 989B | 909B | 1,430B |
| Total Equity | 3,109B | 3,534B | 2,514B |
▲ 13.1%
▲ 205.4%
▲ 182.4%
▼ 23.0%
▼ 759.9%
| Name | Position | Role |
|---|---|---|
| 오원일 | 대표이사 | 대표 |
| NPS Subscribers | 329persons |
| CEO | 오원일 |
| Est. Avg. Annual Salary | 5,31610K (44310K/mo) |
| Hired (12 mo) | +5persons |
| Left (12 mo) | -3persons |
| Net Change (12 mo) | +2persons |
| NPS Join Date | 2000-07-01 |
| Patent Title | Applicant | Application No. | Filing Date | Status |
|---|---|---|---|---|
| PTX-3, TIMP1 및 BDNF를 발현하는 간엽줄기세포를 유효성분으로 포함하는 염증 질환 또는 통증의 예방 또는 치료용 약학 조성물 | 메디포스트(주) | 1020240137013 | 2024-10-08 | 공개 |
| PTX-3, TIMP1 및 BDNF를 발현하는 간엽줄기세포를 유효성분으로 포함하는 염증 질환 또는 통증의 예방 또는 치료용 약학 조성물 | 메디포스트(주) | 1020210178149 | 2021-12-13 | 등록 |
| CD47 과발현 중간엽 줄기세포를 포함하는 폐 질환 예방 또는 치료용 조성물 | 메디포스트(주) | 1020210170214 | 2021-12-01 | 등록 |
| PTX-3, TIMP1 및 BDNF를 발현하는 간엽줄기세포를 유효성분으로 포함하는 염증 질환 또는 통증의 예방 또는 치료용 약학 조성물 | 메디포스트(주) | 1020210009736 | 2021-01-22 | 등록 |
| 히알루론산과 줄기세포를 포함하는 연골손상 관련 질환 치료용 약학 조성물 | 메디포스트(주) | 1020257037074 | 2019-06-05 | 공개 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
2 Additional Data Sources
{
"address": "경기 성남시",
"ceo_name": "오원일",
"certificate": [
{
"cert_number": "20011622712972",
"changes": "",
"disclosure_date": "2001-03-31",
"first_cert_date": "2001-03-31",
"no": "1",
"type": "신기술기업(고도기술수반산업)",
"valid_period": "2001-03-31 ~ 2003-03-30"
},
{
"cert_number": "031622032200347",
"changes": "",
"disclosure_date": "2003-03-31",
"first_cert_date": "2001-03-31",
"no": "2",
"type": "신기술기업(고도기술수반산업)",
"valid_period": "2003-03-31 ~ 2005-03-30"
},
{
"cert_number": "051122032301148",
"changes": "",
"disclosure_date": "2005-03-31",
"first_cert_date": "2001-03-31",
"no": "3",
"type": "신기술기업(고도기술수반산업)",
"valid_period": "2005-03-31 ~ 2007-03-30"
},
{
"cert_number": "20070400070",
"changes": "",
"disclosure_date": "2007-03-28",
"first_cert_date": "2001-03-31",
"no": "4",
"type": "연구개발유형",
"valid_period": "2007-03-31 ~ 2009-03-30"
},
{
"cert_number": "20090400160",
"changes": "",
"disclosure_date": "2009-03-18",
"first_cert_date": "2001-03-31",
"no": "5",
"type": "연구개발유형",
"valid_period": "2009-03-31 ~ 2011-03-30"
},
{
"cert_number": "20110400125",
"changes": "",
"disclosure_date": "2011-04-06",
"first_cert_date": "2001-03-31",
"no": "6",
"type": "연구개발유형",
"valid_period": "2011-03-31 ~ 2013-03-30"
},
{
"cert_number": "20150400654",
"changes": "",
"disclosure_date": "2015-06-04",
"first_cert_date": "2001-03-31",
"no": "7",
"type": "연구개발유형",
"valid_period": "2015-06-04 ~ 2017-06-03"
},
{
"cert_number": "20170401038",
"changes": "",
"disclosure_date": "2017-06-20",
"first_cert_date": "2001-03-31",
"no": "8",
"type": "연구개발유형",
"valid_period": "2017-06-04 ~ 2019-06-03"
},
{
"cert_number": "20190401216",
"changes": "",
"disclosure_date": "2019-06-03",
"first_cert_date": "2001-03-31",
"no": "9",
"type": "연구개발유형",
"valid_period": "2019-06-04 ~ 2021-06-03"
},
{
"cert_number": "20210804030051",
"changes": "",
"disclosure_date": "2021-08-04",
"first_cert_date": "2001-03-31",
"no": "10",
"type": "혁신성장유형",
"valid_period": "2021-06-04 ~ 2024-06-03"
},
{
"cert_number": "20241010010039",
"changes": "",
"disclosure_date": "2024-10-10",
"first_cert_date": "2001-03-31",
"no": "11",
"type": "벤처투자유형",
"valid_period": "2024-10-10 ~ 2027-10-09"
}
],
"company_name": "메디포스트(주)",
"financials": {
"2022": {
"capital_stock": 79178554000,
"cost_of_sales": 25335270000,
"current_assets": 141107551000,
"current_liabilities": 82410624000,
"gross_profit": 36058517000,
"net_income": 10386988000,
"net_income_bs": 6020555000,
"non_current_assets": 253268255000,
"non_current_liabilities": 60545958000,
"non_operating_expenses": 16730532000,
"non_operating_income": 37885097000,
"operating_profit": -10767577000,
"revenue": 61393787000,
"sga_expenses": 46826094000,
"total_assets": 394375806000,
"total_equity": 251419224000,
"total_liabilities": 142956582000
},
"2023": {
"capital_stock": 57803497000,
"cost_of_sales": 30370586000,
"current_assets": 160929941000,
"current_liabilities": 18397544000,
"gross_profit": 39336237000,
"net_income": 6682729000,
"net_income_bs": 7254385000,
"non_current_assets": 283403876000,
"non_current_liabilities": 72492821000,
"non_operating_expenses": 44157861000,
"non_operating_income": 47242955000,
"operating_profit": 3597635000,
"revenue": 69706823000,
"sga_expenses": 35738602000,
"total_assets": 444333817000,
"total_equity": 353443452000,
"total_liabilities": 90890365000
},
"2024": {
"capital_stock": 75227622000,
"cost_of_sales": 29416938000,
"current_assets": 107624114000,
"current_liabilities": 18738165000,
"gross_profit": 44695990000,
"net_income": -61783291000,
"net_income_bs": -62220839000,
"non_current_assets": 302192406000,
"non_current_liabilities": 80149272000,
"non_operating_expenses": 74453590000,
"non_operating_income": 8890233000,
"operating_profit": 3780066000,
"revenue": 74112928000,
"sga_expenses": 40915924000,
"total_assets": 409816520000,
"total_equity": 310929083000,
"total_liabilities": 98887437000
}
},
"industry": "기초 의약 물질 제조업",
"investment": [
{
"amount": "5,247,153,995",
"changes": "5,247,153,995",
"date": "2023-10-31"
}
],
"phone": "02-3465-****",
"source": "pg_migration"
}{
"address": "경기도 성남시 분당구 대왕판교로644번길",
"brno": "211866****",
"cappedWarning": false,
"companyName": "메디포스트(주)",
"estimatedAvgAnnualSalary": 53162292,
"estimatedAvgMonthlySalary": 4430191,
"fetchedAt": "2026-03-05T12:08:18.043Z",
"industryCode": "242309",
"industryName": "의료용품 및 기타 의약 관련제품 제조업",
"joinDate": "20000701",
"last12MonthsHired": 5,
"last12MonthsLeft": 3,
"last12MonthsNetChange": 2,
"leaveDate": null,
"monthlyPensionAmount": 138465620,
"monthlyTrend": [
{
"lostSubscribers": 3,
"newSubscribers": 5,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6636142",
"status": "1",
"styleCode": "1",
"subscriberCount": 329,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | Public Data | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| SME Status Info | 2026-03-05 | Collected |
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-26 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |